
usd may pm et
summari develop manufactur market medic equip treatment
diagnosi sleep-disord breath
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
feb pm stock trade
follow sale growth fy jun
forecast revenu rise fy
fy rmd new product
grow public awar sleep-disord
expect gross margin fy
fy fy
expect margin improv driven
continu manufactur procur
effici partial off-set typic price
grow focu
software-as-a-servic saa busi
key long-term growth driver view
aim expand saa solut
lead health care inform
improv out-of-hospit care transit
oper joint ventur verili
acceler awar sdb view
allow particip broader health
hold opinion reflect view
share trade forward earn
near intrins valu continu face
price pressur robust
growth sale volum adopt
new product increasingli
comfort sleep apnea mask flow
gener track patient complianc
expect sustain momentum awar
sdb increas saa busi fy
net revenu vs fy
focus drive improv patient outcom
busi effici out-of-hospit
commit improv patient complianc
think effort valu
mani third-parti payer patient
risk recommend target price
liabil weak adopt trend reduc
reimburs willing third-parti
target price base dcf
model reflect forward price-to-earnings
ep share
experienc multipl expans recent due
product launch shift toward
oper fairli competit market face
constant pressur third-parti payer howev
product servic becom increasingli
accept compani histor maintain
manag level debt factor lead us
rate compani oper risk medium
jul ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview resm inc engag develop manufactur distribut
medic equip treat diagnos manag respiratori disord includ
chronic diseas rmd product market approxim countri
compani portfolio product treatment obstruct sleep apnea osa form
sdb includ air flow gener diagnost product mask system headgear accessori
produc continu posit airway pressur cpap variabl posit airway pressur vpap
autoset system titrat treatment sdb market sleep record diagnosi
treatment sdb sleep clinic hospit also grow cloud-bas softwar
informat solut busi rmd out-of-hospit softwar product design support
profession caregiv help peopl stay healthi variou set outsid hospit
rmd devic air flow gener ventil oxygen concentr account approxim
fy jun revenu previou two year mask accessori motor
diagnost product account remain rmd fy revenu came saa
busi prior year
compani diagnost system record relev respiratori sleep data analyz
sleep specialist physician modifi appropri osa treatment regimen patient
assist profession diagnos manag treatment patient data
commun control product reslink rescontrol rescontrol ii txcontrol resscan
restraxx modul facilit transfer data inform flow
gener compani market variou product accessori includ humidifi
humidair connect directli cpap vpap autoset flow gener
humidifi heat air deliv patient option accessori includ cold passov
humidifi carri bag breath circuit
corpor strategi see growth sdb market futur attribut
posit number factor includ increas awar osa improv understand
role sdb treatment manag cardiac neurolog metabol relat disord
increas home-bas diagnosi busi strategi includ follow critic compon
continu product develop innov sdb respiratori care product expans
saa solut out-of-hospit care set expans geograph presenc increas
public clinic awar expans new clinic applic leverag experi
manag team
major develop made two major acquisit addit sever tuck-in
acquisit januari total purchas consider million acquir
propel health digit therapeut compani provid connect health solut peopl live
chronic obstruct pulmonari diseas asthma novemb acquir matrixcar inc
subsidiari provid softwar solut skill nurs life plan commun senior live
privat duti base purchas consider paid million
make major acquisit april acquir brightre llc
expand rmd offer includ suppli busi manag softwar servic
medic equip home health provid
financi trend fiscal year end june revenu increas
billion reflect five-year compound annual growth rate compound-annual-growth-rate adjust earn per share
increas year-over-year reflect five-year compound-annual-growth-rate free cash flow
million vs million june moder net debt total
capit ratio low leverag ratio net debt trailing-twelve-month ebitda
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu usd
bullish sinc april technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
next month neg
recess concern although
medic devic sub-industri
histor defens recess resist
nonetheless expect near-term result
wors recent year despit neg
outlook think medic devic compani
fare much better compani
industri health care essenti
peopl expect
neg impact global procedur volum
procedur volum could quickli return
worst diseas impact pass
continu achiev robust organ growth
 mid-to-high single-digit revenu growth
driven new product grow
emerg market exposur howev expect
revenu neg impact
basi point result
mean anticip organ growth
low-single-digit
long run gener see posit
fundament trend medic devic
demand cost-effect value-bas health
care age popul rise outlay
result steadi flow
innov product revenu growth
 medic devic regul
mdr go effect may
follow vitro devic
regul ivdr goe effect
devic compani made much commentari
around introduct mdr reason
believ new regul could
neg impact industri exampl
juli submit letter
world trade organ request
mdr ivdr delay three year also
novemb european medic devic
trade associ critic slow
piecem implement new
accord evalu
billion valu prior
five-year averag deal total
billion industri debt level measur
net debt rel total capit appear
declin substanti follow
sever year increas think
industri could see increas deal
especi new ceo sever
major firm
prior concern expect
industri earn rise low-double-digit
percentag driven sale new product
command higher margin expect
industri earn rise mid-single-digit
percentag origin project
industri oper ebit margin
estim margin
think margin
like flat year-over-year
year date march health
equip sub-index declin
vs declin
composit index health
increas valu
base index
five-year market price perform may
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
lift target base
ep estim toward high end pe rang
promis growth opportun mar-q ep vs
higher estim rais june ep estim
lower ep estim mar-q sale
increas constant currenc cc million
expect revenu america exclud saa grew cc
year-over-year driven growth mask sale sale europ asia
market also grew cc led mask sale well adjust gross
margin expand basi point bp yoy bp come
matrixcar acquisit begun integr saa asset
believ support compani long-term strategi drive improv
patient outcom busi effici out-of-hospit health care set
et cfra maintain hold opinion share resm inc
lower target
ep estim toward high end three-year
price-to-earnings rang dec-q ep vs higher
estim lower june ep estim
ep dec-q sale increas constant
currenc million sale america exclud saa grew
year-over-year sale europ asia market grew
constant currenc basi expect devic sale declin
constant currenc term manag refrain provid detail
commentari factor drive weaker-than-expect devic growth
continu expand invest digit health dec-q
compani acquir propel health propel offer platform help
doctor better manag chronic obstruct pulmonari diseas copd asthma
analyst research note compani news
pm et cfra keep hold opinion share resm inc
keep target price base discount cash flow model
reflect forward price-to-earnings multipl ep estim
mar-q ep vs consensu surg demand
ventil use world-wide tackl sever case
rais fy jun ep estim keep
fy ep mar-q sale grew yoy constant currenc
cc million revenu market outsid
america grew cc growth preced quarter driven
sale mask devic ventil meanwhil sale america
exclud saa grew preced quarter
jun-q anticip headwind sleep devic sale due temporari
reduct new patient overal expect net tailwind
long-run think could acceler public
awar sleep-disord breath /kevin huang cfa
pm et cfra keep hold opinion share resm inc
lift target price base discount cash flow
model reflect forward price-to-earnings vs one-year rang
ep estim dec-q ep vs beat
consensu estim stronger-than-expect mask sale
rais fy jun ep estim fy ep
dec-q sale increas yoy constant currenc
cc million sale mask accessori
mask grew cc global ahead market growth rate mask sale growth
led growth america follow cc growth rest
world row mask sale strong due recent product launch
increas patient adher result rmd digit health solut
meanwhil devic sale grew cc global saa revenu grew
high-single-digit exclud impact matrixcar acquisit
et cfra keep hold opinion share resm inc
rais target price base ep
estim high-end price-to-earnings rang
promis growth opportun sep-q ep vs exceed
estim rais fy jun ep estim
fy ep sep-q sale increas
constant currenc cc million expect
led cc growth global sale mask accessori strength
mask aid four new mask launch past year organ
basi saa busi grew high singl digit aim exit
fy solid double-digit growth saa busi
meanwhil devic busi grew cc in-lin fy devic growth
sep-q gross margin expand bp primarili due manufactur
procur effici aid higher margin contribut
et cfra keep hold opinion share resm inc
lift target price base ep
estim high-end price-to-earnings rang promis
growth opportun jun-q ep vs in-lin
estim rais jun ep estim
initi ep jun-q sale increas constant
currenc cc million slightli expect
revenu america exclud saa grew cc year-over-year driven
except growth mask sale america sale europ asia
market grew cc led mask sale rmd gross
margin expand basi point yoy in-lin expect
primarili due contribut matrixcar manufacturing/procur
effici partial off-set declin averag sell price overal
solid quarter expect /kevin huang cfa
et cfra maintain hold opinion share resm inc
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
redistribut reproduct prohibit without prior written permiss copyright cfra
content includ rate credit-rel analys data valuat model softwar
applic output therefrom part thereof content may modifi
revers engin reproduc distribut form mean store
databas retriev system without prior written permiss cfra content shall
use unlaw unauthor purpos cfra third-parti provid
well director offic sharehold employe agent guarante
accuraci complet timeli avail content
past perform necessarili indic futur result
document may contain forward-look statement forecast forecast
reliabl indic futur perform
report intend constitut offer solicit buy sell
secur engag invest activ report inform purpos
recommend report made respect particular investor
type investor secur financi instrument strategi mention herein may
suitabl investor materi intend specif investor
take account investor particular invest object financi situat
need act recommend materi consid whether
suitabl particular circumst necessari seek profession advic
cfra may licens certain intellectu properti provid servic otherwis
busi relationship certain issuer secur subject cfra
research report includ exchange-trad invest whose invest object
substanti replic return proprietari index cfra case cfra
paid fee tie amount asset invest fund volum trade
activ fund invest fund may result cfra receiv compens
addit subscript fee compens servic render cfra
howev part cfra compens servic tie recommend
rate addit inform subject compani may avail upon request
cfra financi data provid global market intellig document contain
global industri classif standard gic develop and/or exclus
properti inc global market intellig gic servic mark
 global market intellig licens use cfra
disclaim notic
certain inform report provid global inc and/or affili
subsidiari collect global inform subject follow
disclaim notic copyright global market intellig affili
applic right reserv noth contain herein invest advic
refer particular invest secur credit rate observ
concern secur invest provid recommend buy
sell hold invest secur make invest decis may
contain inform obtain third parti includ rate credit rate
agenc reproduct distribut inform third parti content
form prohibit except prior written permiss global
relat third parti applic neither third parti provid guarante
accuraci complet timeli avail inform includ rate
respons error omiss neglig otherwis regardless
caus result obtain use inform content
includ rate credit rate statement opinion statement
fact recommend purchas hold sell secur address
suitabl secur suitabl secur invest purpos
reli invest advic
